Ovarian cancer standard of care: are there real alternatives?

Chin J Cancer · 2015 · PMC4302086 · PMID 25556615

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

The PFS was statistically longer in the bevacizumab arm (6.7 versus 3.4 months, HR = 0.46, P < 0.001), and OS data showed a favorable trend for the experimental arm (16.6 versus 13.3 months) but without statistical significance.

also in 1,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.